Dexcel Pharma
Itamar Yaron-Enden has a strong background in business development, corporate strategy, and consulting across various industries. With experience at companies like Dexcel Pharma, NRGene Ltd., and Teva Pharmaceuticals, Itamar has led significant sell-side divestment deals and corporate M&A processes. Itamar also has a background in science, with a Master's degree in Life Sciences and experience as a science teacher.
Previous companies
This person is not in any offices